Cargando…
Vascular calcification in patients with type 2 diabetes: the involvement of matrix Gla protein
BACKGROUND: Matrix Gla protein (MGP) is an important inhibitor of calcification. The objective of the present study of patients with type 2 diabetes and normal or slightly altered kidney function was to evaluate levels of inactive, dephospho-uncarboxylated MGP(dp-ucMGP) and total uncarboxylated MGP(...
Autores principales: | Liabeuf, Sophie, Olivier, Bourron, Vemeer, Cees, Theuwissen, Elke, Magdeleyns, Elke, Aubert, Carole Elodie, Brazier, Michel, Mentaverri, Romuald, Hartemann, Agnes, Massy, Ziad A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4017083/ https://www.ncbi.nlm.nih.gov/pubmed/24762216 http://dx.doi.org/10.1186/1475-2840-13-85 |
Ejemplares similares
-
Erratum: Vascular calcification in patients with type 2 diabetes: the involvement of matrix Gla protein
por: Liabeuf, Sophie, et al.
Publicado: (2015) -
Inactive matrix gla protein plasma levels are associated with peripheral neuropathy in Type 2 diabetes
por: Jeannin, Anne-Caroline, et al.
Publicado: (2020) -
Correction: Inactive matrix gla protein plasma levels are associated with peripheral neuropathy in Type 2 diabetes
por: Jeannin, Anne-Caroline, et al.
Publicado: (2020) -
Association between metformin use and below-the-knee arterial calcification score in type 2 diabetic patients
por: Mary, Aurélien, et al.
Publicado: (2017) -
Circulating Receptor Activator of Nuclear Factor kB Ligand and triglycerides are associated with progression of lower limb arterial calcification in type 2 diabetes: a prospective, observational cohort study
por: Bourron, Olivier, et al.
Publicado: (2020)